Tech Company Financing Transactions
Phoenix PharmaLabs Funding Round
Phoenix PharmaLabs closed a financing round on 4/9/2019. Investors included Netcapital.
Transaction Overview
Company Name
Announced On
4/9/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Netcapital (Jackson Stone)
Proceeds Purpose
Funds to accelerate development of first non-addictive opioid
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
999 West 1500 South 600
Woodscross, UT 84087
USA
Woodscross, UT 84087
USA
Phone
Website
Email Address
Overview
Phoenix PharmaLabs, Inc. (PPL) is a privately held, pre-clinical stage drug development company headquartered in Utah focusing on the development and commercialization of new non-addictive treatments for pain and new therapies for the treatment of opiate addiction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Crossman
Chief Financial Officer
Timmy Chou
Chief Scientific Officer
John Lawson
Founder
Lawrence Toll
Vice President
Chris Tew
Browse more venture capital transactions:
Prev: 4/9/2019: SHO Products venture capital transaction
Next: 4/10/2019: Make School venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs